4
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001628280-24-006433
Chief Financial Officer acquired 33,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Byrne Jason Chief Financial Officer | 2024-02-20 | Grant or award | +33,000 | 59,224 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Byrne Jason Chief Financial Officer | 2024-02-20 | Grant or award · Option to purchase Common Stock | +153,000 | 153,000 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1708640897.xml…